Effects of eplerenone on glucose metabolism and blood pressure in hypertensive patients with obesity

Trial Profile

Effects of eplerenone on glucose metabolism and blood pressure in hypertensive patients with obesity

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 13 May 2016

At a glance

  • Drugs Eplerenone (Primary) ; Trichlormethiazide
  • Indications Hypertension
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 20 Apr 2016 Status changed from recruiting to active, no longer recruiting.
    • 17 Apr 2015 According to UMIN, the date for data entry closure is 2016/12/31, and the date for conclusion of data analysis is 2017/02/28.
    • 17 Apr 2015 Planned End Date changed from 31 Dec 2015 to 30 Sep 2016 as reported by University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top